Drug updated on 11/16/2023
|Tablet (oral: 150 mg, 200 mg)
|Gonadotropin-releasing hormone (GnRH) receptor antagonists
|Ongoing and Completed Studies
- To manage the moderate to severe pain associated with endometriosis.
Product Monograph / Prescribing Information
|Orilissa (elagolix) Prescribing Information.
|AbbVie Inc., North Chicago, IL
Systematic Reviews / Meta-Analyses
|Efficacy and safety of oral gonadotropin-releasing hormone antagonists in moderate-to-severe endometriosis-associated pain: a systematic review and network meta-analysis.
|Archives of Gynecology and Obstetrics
|Systematic review of oral pharmacotherapeutic options for the management of uterine fibroids.
|Journal of the American Pharmacists Association
|Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis.
|BMC Women’s Health
|Efficacy and safety of oral GnRh antagonists in patients with uterine fibroids: a systematic review.
|Journal of Obstetrics and Gynecology Canada
|Elagolix for treating endometriosis.